Cerner Co. (CERN) Receives Average Recommendation of “Buy” from Brokerages

Shares of Cerner Co. (NASDAQ:CERN) have received a consensus rating of “Buy” from the twenty-one analysts that are covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $69.05.

Several equities research analysts have recently weighed in on the stock. Stifel Nicolaus lowered their price target on shares of Cerner from $71.00 to $62.00 and set a “hold” rating for the company in a research report on Thursday, May 3rd. Canaccord Genuity reduced their price objective on shares of Cerner from $73.00 to $64.00 and set a “buy” rating for the company in a research note on Thursday, May 3rd. KeyCorp reduced their price objective on shares of Cerner from $85.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, April 2nd. SunTrust Banks reduced their price objective on shares of Cerner to $58.00 in a research note on Friday, May 4th. Finally, BidaskClub upgraded shares of Cerner from a “sell” rating to a “hold” rating in a research note on Thursday, May 31st.

In other Cerner news, Chairman David Brent Shafer sold 13,348 shares of the company’s stock in a transaction that occurred on Monday, May 21st. The shares were sold at an average price of $61.36, for a total transaction of $819,033.28. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Vice Chairman Clifford W. Illig sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $58.32, for a total transaction of $174,960.00. Following the transaction, the insider now owns 1,229,719 shares in the company, valued at approximately $71,717,212.08. The disclosure for this sale can be found here. In the last quarter, insiders have sold 275,848 shares of company stock valued at $16,650,169. 4.71% of the stock is currently owned by company insiders.

Institutional investors have recently modified their holdings of the business. MV Capital Management Inc. acquired a new position in Cerner during the 1st quarter valued at approximately $116,000. Archford Capital Strategies LLC acquired a new position in Cerner during the 1st quarter valued at approximately $181,000. Cedar Hill Associates LLC acquired a new position in Cerner during the 4th quarter valued at approximately $200,000. TLP Group LLC increased its stake in Cerner by 856.1% during the 1st quarter. TLP Group LLC now owns 3,442 shares of the company’s stock valued at $200,000 after purchasing an additional 3,082 shares in the last quarter. Finally, Signature Financial Management Inc. acquired a new position in Cerner during the 1st quarter valued at approximately $238,000. Institutional investors and hedge funds own 77.72% of the company’s stock.

Shares of CERN opened at $61.03 on Tuesday. Cerner has a fifty-two week low of $52.05 and a fifty-two week high of $73.86. The company has a market capitalization of $20.40 billion, a PE ratio of 27.74, a price-to-earnings-growth ratio of 1.95 and a beta of 0.96. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.95 and a quick ratio of 2.93.

Cerner (NASDAQ:CERN) last announced its quarterly earnings results on Wednesday, May 2nd. The company reported $0.58 earnings per share for the quarter, hitting the consensus estimate of $0.58. Cerner had a net margin of 16.50% and a return on equity of 15.80%. The firm had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.34 billion. During the same quarter in the prior year, the company earned $0.59 EPS. The company’s revenue was up 2.6% compared to the same quarter last year. equities analysts expect that Cerner will post 2.28 EPS for the current year.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Read More: Earnings Per Share

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply